With 20.41% CAGR, Biosimilar Market in Europe Growth to Surpass US$ 35,993 Million Till 2023-28

How big is the Biosimilar Market in Europe?

According to the latest report by IMARC Group, titled "Biosimilar Market in Europe: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the biosimilar market in Europe size reached US$ 9,841 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 35,993 Million by 2028, exhibiting a growth rate (CAGR) of 20.41% during 2023-2028.

Request for a PDF sample of this report: https://www.imarcgroup.com/europe-biosimilar-market/requestsample

What is Biosimilar?

Biosimilars are medical products that are generally manufactured from biological substances, such as microorganisms and animal or plant cells. They are extensively used in the production of vaccines, therapeutic proteins and monoclonal antibodies. Additionally, they are utilized by healthcare professionals for preventing, determining, and treating numerous medical ailments. These products are usually produced under the guidance of licensed facilities that are tracked as an essential part of post-market surveillance. They are considered to be harmless and safe for medical use with minor differences in clinically inactive components.    

What are the growth prospects and trends in the biosimilars industry?

The market in Europe is primarily driven by the rising prevalence of chronic illnesses due to the sedentary lifestyle patterns of the masses. Additionally, the multiple initiatives undertaken by the governments of numerous countries towards the development of a comprehensive set of stringent regulatory guidelines for biosimilar review are positively influencing the market growth across the region. Furthermore, increasing investments and funding by private and public agencies to upgrade the existing healthcare infrastructure and various technological advancements across the sector are considered to be major growth-inducing factors. Other factors, including the rising awareness regarding the availability of biosimilars among patients, patent expiration of numerous blockbuster biologics and extensive research and development (R&D) activities conducted by key players in biotechnology and medical science, are further projected to drive the market growth across Europe.

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=1023&flag=E

Who are the key players operating in the industry?

The report covers the major market players including: 

  • Novartis
  • Pfizer
  • Teva
  • Celltrion
  • Samsung Bioepis
  • Amgen
  • Apotex
  • Ratiopharm
  • Mylan
  • Merck Sharp & Dohme
  • Eli Lilly
  • Accord Healthcare Ltd
  • Boehringer Ingelheim
  • Hexal Ag
  • Stada Arzneimittel Ag

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Country:

  • Italy
  • Germany
  • United Kingdom
  • France
  • Spain
  • Rest of Europe

Breakup by Molecule:

  • Infliximab
  • Insulin Glargine
  • Epoetin Alfa
  • Etanercept
  • Filgrastim
  • Somatropin
  • Rituximab
  • Follitropin Alfa
  • Adalimumab

Breakup by Indication:

  • Auto-Immune Diseases
  • Blood Disorder
  • Diabetes
  • Oncology
  • Growth Deficiency
  • Female Infertility

Breakup by Manufacturing Type:

  • In-house Manufacturing
  • Contract Manufacturing

Buy Now: https://www.imarcgroup.com/checkout?id=1023&method=7

Key Highlights of the Report:

  • Market Performance (2017-2022)
  • Market Outlook (2023- 2028)
  • Porter's Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us:                                                                     

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact Us:

IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Popular posts from this blog

Europe Beer Market Share, Size, Forecast & Analysis 2023-2028

Image
IMARC Group, a leading market research company, has recently releases report titled “Europe Beer Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”. The study provides a detailed analysis of the industry, including the   Europe beer market share , size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. How Big is the Europe Beer Market? The Europe beer market size reached US$ 146.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 167.7 Billion by 2028, exhibiting a growth rate (CAGR) of 2.4% during 2023-2028. Request to Get the Sample Report: https://www.imarcgroup.com/europe-beer-market/requestsample Factors Affecting the Growth of the Europe Beer Industry:     Shifting Consumer Preferences: The beer market in Europe is experiencing notable growth as consumer preferences undergo continuous evolution. In addition to this, ther...
Read more

GCC LED Lighting Market Size, Trends, Growth, Forecast & Industry Report 2024-2032

Image
According to IMARC Group, the GCC led lighting market share reached us$ 876.9 million in 2023 . Looking forward, Imarc group expects the market to reach us$ 2,174.9 million by 2032, exhibiting a growth rate (CAGR) of 10.3% during 2024-2032. The report has segmented the market by product type (panel lights, down lights, street lights, and others), application (residential, commercial, industrial, and others), import and domestic manufacturing (imports, domestic manufacturing), public and private sectors (public sector, private sector), outdoor and indoor application (indoor, outdoor), and region. Request to Get the Sample Report: https://www.imarcgroup.com/gcc-led-lighting-market/requestsample What is the LED Lighting Market ? Light Emitting Diode (LED) lighting has emerged as a transformative technology in the field of illumination, revolutionizing the lighting solutions are perceived and utilized. LEDs are semiconductor devices that emit light when an electrical current passes...
Read more

Bulletproof Glass Manufacturing Plant Project Report 2024: Industry Trends, Unit Setup and Machinery

Image
IMARC Group’s report, titled “ Bulletproof Glass Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue ” provides a complete roadmap for setting up a  bulletproof glass manufacturing plant . The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more. In addition to the operational aspects, the report also provides in-depth insights into bulletproof glass manufacturing process, project economics, encompassing vital aspects such as capital investments, project funding, operating expenses, income and expenditure projections, fixed and variable costs, direct and indirect expenses, expected ROI, net present value (NPV), profit and loss account, and thorough financial analysis, amon...
Read more